Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2
Written By : Ruchika Sharma
Published On 2025-11-15 09:57 GMT | Update On 2025-11-15 09:57 GMT
New Delhi: Natco Pharma has announced a 23.44 percent drop in its consolidated net profit for the second quarter ending September 30, 2025. The company reported a consolidated net profit of Rs 517.9 crore, compared to Rs 676.5 crore in the same period of the previous fiscal year.
The decline was attributed to higher research and development (R&D) expenses and a one-time employee bonus.
Consolidated revenue from operations in the second quarter stood at Rs 1,363 crore, as against Rs 1,371.1 crore in the corresponding period last fiscal, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.